ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

UC Davis Coordinates Asian American Network

September 27, 2002

NIH funds four centers to study breast cancer and the environment.

October 17, 2003

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980

New Diet Trial Is Described In Concept

October 26, 1990

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989